Press release
HIV Drugs Market Is Predicted To Boom Worldwide In The Forecast Period 2022-2031 | ViiV Healthcare, Gilead Sciences, Merck & Co., Inc., Bristol-Myers Squibb Company
HIV Drugs Market
The regions covered in the HIV drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. Among these regions, North America accounts for the largest HIV drugs market share.
Request For A Sample Of The HIV Drugs Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2834&type=smp
The HIV drugs market consists of sales of Human Immunodeficiency Virus (HIV) drugs used for the treatment of HIV infection/AIDS. The market consists of revenue generated by the antiretroviral drug companies manufacturing the anti-retroviral drugs such as nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), entry and fusion inhibitors, integrase inhibitors, and protease inhibitors (PIs) for the treatment of HIV infection.
Key competitors in the HIV drugs market include ViiV Healthcare, Gilead Sciences, Merck & Co., Inc., Bristol-Myers Squibb Company, Janssen (Johnson&Johnson), F. HOFFMANN-LA ROCHE LTD, Boehringer Ingelheim (C.H. Boehringer Sohn AG & Ko. KG), AbbVie, Inc., GlaxoSmithKline plc, Mylan Pharmaceuticals, Pfizer, TEVA PHARMACEUTICAL INDUSTRIES LTD, Hetero Drugs, Daiichi Sankyo, Emcure, AstraZeneca, CIPLA, Alexion Pharmaceuticals, Shionogi, Theratechnologies, and Abbott Laboratories Inc.
The global HIV drugs market size is expected to grow from $31.23 billion in 2021 to $33.39 billion in 2022 at a compound annual growth rate (CAGR) of 6.9%. The change in the HIV drugs market growth trend is mainly due to the companies stabilizing their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2020. The HIV drugs market is expected to reach $40.32 billion in 2026 at a CAGR of 4.8%.
Need more for your business growth? Directly purchase the report here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2834
TBRC's report segments the global HIV drugs market:
1) By Type: Nucleoside Reverse Transcriptase Inhibitors (NRTs), Non- Nucleoside Reverse Transcriptase Inhibitors (NNRTs), Protease Inhibitors, Integrate Inhibitors, Fusion Inhibitors, Chemokine Receptor Inhibitors, Others
2) By Application: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others
3) By Administration: Oral, Parenteral
Read Further On The HIV Drugs Market Here:
https://www.thebusinessresearchcompany.com/report/hiv-drug-global-market-report
The Table of Contents includes:
1. Executive Summary
2. HIV Drugs Market Characteristics
3. HIV Drugs Market Trends And Strategies
4. Impact Of COVID-19 On HIV Drugs
5. HIV Drugs Market Size And Growth
.....
28. HIV Drugs Pipeline Analysis
29. Key Mergers And Acquisitions In The HIV Drugs Market
30. HIV Drugs Market Future Outlook and Potential Analysis
31. Appendix
Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
And check out our Blog: http://blog.tbrc.info/
Interested to know more about The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that excels in company, market, and consumer research. Located globally, it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.
The World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release HIV Drugs Market Is Predicted To Boom Worldwide In The Forecast Period 2022-2031 | ViiV Healthcare, Gilead Sciences, Merck & Co., Inc., Bristol-Myers Squibb Company here
News-ID: 2562018 • Views: …
More Releases from The Business research com
Engineering Services Market Size, Analysis, Forecast to 2026 | Key Players Tata …
New year, new updates! Our reports have been revised for market size, forecasts, and strategies to take on 2022
https://www.thebusinessresearchcompany.com/global-market-reports
Engineering Services Global Market Report 2022 –Market Size, Trends, And Global Forecast 2022-2026 by The Business Research Company is the most comprehensive report available on this market, with analysis of the market’s historic and forecast growth, drivers and restraints causing it, and highlights of the opportunities that companies in the industry can…
More Releases for HIV
HIV Drugs Market - Defeating HIV Together: Advancing Treatment Options for a Bri …
Newark, New Castle, USA: The "HIV Drugs Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
HIV Drugs Market: https://www.growthplusreports.com/report/hiv-drugs-market/7792
This latest report researches the industry structure, sales, revenue,…
HIV-Associated Lipodystrophy Treatment Market - Increasing prevalence of HIV is …
HIV-associated lipodystrophy also known as lipodystrophy is a syndrome that occurs in HIV-infected patients. It is characterized by loss of subcutaneous fat from face, buttocks, arms and legs. Although the exact cause of HIV-associated lipodystrophy is not fully elucidated, some research evidence reported that it occurs in HIV-infected patients who are under antiretroviral medications. According to an article published in National Center for Biotechnology Information (NCBI) in 2014, prevalence of…
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication…
HIV Therapeutics Market– South Africa's Aspen launches three-in-one HIV drug
Recent Developments
Aspen Pharma care, a South Africa’s drug maker has launched a triple combination of tablet for the treatment of HIV in the country where the HIV virus is the most prevalent. The company's new Emdolten drug is a once a day tablet which is in the form of dolutegravir, an antiretroviral medication that balances the drug’s resistance. The company has launched Aspen Stavudine which was its first generic ARV…
HIV Vaccine Market HIV Vaccine Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
Introduction to Human Immunodeficiency Virus (HIV) Vaccines
1.1 Overview
1.2 Antiquity of HIV Vaccine
Need for the Development of HIV Vaccine
Primer of HIV inside the Body
3.1 Inclusion of HIV Virus into the System
3.2 Interaction of HIV with Host
3.3 Eradication of HIV Virus
HIV Vaccine Development Process
4.1 Introduction
…
Global HIV Vaccine Market & HIV Vaccine Clinical Trial Outlook 2022
Worldwide, around the 35 Million of the people are currently infected with the HIV and about 30 Million of the people died because of the AIDS infection. There is no human example of clearing an HIV infection naturally. HIV virus makes copies of it very quickly, many types of HIV exist and new types of virus are continue to rise. Many scientists are still trying to understand the specific ways…
